Nov 09, 2023 / 01:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Zealand Pharma Results for Q3 2023 Conference Call and Webcast. (Operator Instructions) Please note that today's conference is being recorded.
I would now like to turn the conference over to your first speaker, Anna Krassowska, Head of Investor Relations. Please go ahead.
Anna Krassowska - Zealand Pharma A/S-VP of IR&Corporate Communications
Thank you, operator. Welcome, and thank you for joining us to discuss Zealand's interim results for the first 9 months of 2023. With me today are the following members of Zealand's management team: Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer.
You can also find the related company announcement and interim report on our website at zealandpharma.com. As described on Slide 2, we will be making forward-looking statements that are subject to risks and uncertainties.
With that, I will turn the call
Q3 2023 Zealand Pharma A/S Earnings Call Transcript
Nov 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers